Axios @axios
The FDA has approved Zynteglo, a gene therapy from Bluebird Bio that treats patients with the blood disorder beta-thalassemia. https://t.co/D7oM0jjstj — PolitiTweet.org
Created
Sat Aug 20 11:03:25 +0000 2022
Likes
9
Retweets
6
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
Axios @axios
The FDA has approved Zynteglo, a gene therapy from Bluebird Bio that treats patients with the blood disorder beta-thalassemia. https://t.co/D7oM0jjstj — PolitiTweet.org